Associated Papers
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example.
Zheng S et al.
Molecular Biomedicine, 2024
ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes.
Chen JW et al.
Molecular Oncology, 2023
36892268 (PubMed )
Supplement: MOL2-17-2000-s008.pdf
Multigene Panel Sequencing Reveals Cancer-Specific and Common Somatic Mutations in Colorectal Cancer Patients: An Egyptian Experience.
Youssef ASE et al.
Current Issues in Molecular Biology, 2022
PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival.
Cochicho D et al.
Cancers, 2022
35267596 (PubMed )
Supplement: cancers-14-01286-s001.zip › Table_S3-HNSCC_PIK3CA_Mutational_profile.pdf
The impact of heterogeneity in phosphoinositide 3-kinase pathway in human cancer and possible therapeutic treatments.
Wang W et al.
Seminars in Cell & Developmental Biology, 2017
Novel mutations of PIK3CA gene in head and neck squamous cell carcinoma.
Al-Amri AM et al.
Cancer Biomarkers : Section a of Disease Markers, 2016
Prediction for response duration to epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR mutated never smoker lung adenocarcinoma.
Kim HR et al.
Lung Cancer (amsterdam, Netherlands), 2014
Select a paper to view details